Back to Search
Start Over
A predictive signature for therapy assignment and risk assessment in prostate cancer
- Publication Year :
- 2015
-
Abstract
- Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1105031275
- Document Type :
- Electronic Resource